News
Lung cancer trial has problems in recruitment
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7255.195/a (Published 22 July 2000) Cite this as: BMJ 2000;321:195- Susan Mayor
- London
Nearly three quarters of patients eligible to take part in a UK trial of chemotherapy in non-small cell lung cancer have declined to take part, according to a study published last week that showed fear of side effects to be a major factor in patients' decisions.
The big lung trial (BLT) aims to assess the effectiveness of chemotherapy in treating all stages of non-small cell lung cancer. Lead researcher Stephen Spiro, professor of respiratory medicine …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.